Antivirals for pityriasis rosae [2]

Photodermatology Photoimmunology and Photomedicine

Volumn 20, Issue 2, 2004, Pages 110-

  Castanedo Cazares, Juan Pablo ^a   Lepe, Veronica ^a   Moncada, Benjamin ^a  

^a UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT;

CASE REPORT; DISEASE ASSOCIATION; DISEASE EXACERBATION; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; IMMUNE RESPONSE; LETTER; PHOTOTHERAPY; PITYRIASIS ROSEA; PRIORITY JOURNAL; VIRUS LOAD; VIRUS REACTIVATION;

ACYCLOVIR; ADMINISTRATION, ORAL; ADOLESCENT; ANTIVIRAL AGENTS; HUMANS; MALE; PITYRIASIS ROSEA; ULTRAVIOLET THERAPY;

EID: 1842536512     PISSN: 09054383     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2004.00076.x     Document Type: Letter

References (3)

1. Castanedo-Cazares JP, Lepe V, Moncada B. Should we still use phototherapy for pityriasis rosea? Photodermatol Photoimmunol Photomed 2003; 19: 160-161.
2. Arndt KA, Paul BS, Stern RS, Parrish JA. Treatment of pityriasis rosea with UV radiation. Arch Dermatol 1983; 119: 381-382.
3. Watanabe T, Kawamura T, Jacob SE, et al. Pityriasis rosea is associated with systemic active infection with both human herpesvirus-7 and human herpesvirus-6. J Invest Dermatol 2002; 119: 793-797.